Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia
Bethan Psaila(University of Oxford), Alan D. Michelson(Harvard University), James B. Bussel(Cornell University), Andrew L. Frelinger(University of Nottingham), Matthew D. Linden(University of Massachusetts Chan Medical School), Bracken Babula(Cornell University), Christian Tate(Cornell University), Y. LI(University of Massachusetts Chan Medical School), M.R. BARNARD(Harvard University), Eric J. Feldman(The University of Texas MD Anderson Cancer Center)
Cited by 131
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|877
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
|The Lancet|2009|723
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
|New England Journal of Medicine|2006|530